We use cookies to analyze site usage and improve your experience. You can accept all, reject non-essential, or customize. See our Privacy Policy.
Combination patches deliver both estradiol and progesterone in a single patch — simplifying hormone therapy for women who need both hormones as part of their menopause treatment protocol. Available to women across Michigan's humid continental climate with long winters — entirely online.
Start Your Free Intake →Licensed in Michigan · FDA-registered pharmacy · Reviewed within 24 hours · Ships free
Connect with a kindr-licensed provider who can evaluate whether Combination HRT Patches is appropriate for your health history and symptoms — from anywhere in Michigan.
A combination patch delivers both estradiol and a progestogen through the skin in a single adhesive worn on the lower abdomen or upper hip. It is intended for women with an intact uterus who need both estrogen (for symptom control) and progesterone or a progestin (for endometrial protection). The patch is changed once or twice weekly depending on the formulation.
Two combination transdermal products are widely available: estradiol/norethindrone acetate (Combipatch) and estradiol/levonorgestrel (Climara Pro). Both are FDA-approved for menopausal symptom management in women with an intact uterus.
The estradiol component restores physiologic estrogen signaling in the brain, bone, cardiovascular system, and urogenital tissue — reducing hot flashes, improving sleep, and preserving bone density. The progestogen component prevents estrogen-driven endometrial proliferation, protecting against endometrial hyperplasia and cancer. Transdermal delivery of both components avoids hepatic first-pass metabolism.
Randomized trials of combination transdermal patches (Utian et al., 2005; Speroff et al., 2003) demonstrate significant reduction in vasomotor symptoms, effective endometrial protection, and generally favorable tolerability compared with oral combination products. The NAMS 2022 Position Statement includes combination transdermal HRT among recommended options for symptomatic menopausal women with an intact uterus.
Because progestogens in combination patches are synthetic (norethindrone acetate or levonorgestrel) rather than micronized bioidentical progesterone, individual tolerance and breast tissue effects can differ from bioidentical protocols and are considered in prescribing decisions.
Most side effects are mild and settle within the first 4-8 weeks. Report anything severe or persistent to your prescriber.
Medically reviewed by the kindr Clinical Team. Content reflects the 2022 NAMS Position Statement and current Endocrine Society guidelines. Last reviewed 2026.
Complete your intake online from anywhere in Michigan
A licensed Michigan provider reviews within 24 hours
If prescribed, ships free to your door
A kindr physician evaluates whether a combination patch is appropriate for your symptom profile and health history. Prescribed and shipped monthly from an FDA-registered pharmacy.
In 2025, the FDA updated its guidance on hormone therapy for menopause, removing longstanding warnings that had deterred many women from effective treatment. Speak with a kindr provider about what this means for you.
Connect with a board-certified kindr physician licensed to practice in Michigan. No waiting rooms. No referrals. Reviewed within 24 hours.
Start Your Free Intake →Combination HRT Patches is a prescription medication. A licensed provider must evaluate whether this treatment is right for you. kindr is not a pharmacy. Medications are prescribed by licensed independent physicians and fulfilled by FDA-registered 503A compounding pharmacies. kindr does not guarantee any specific treatment will be prescribed.